FRA1 is recruited to the Cyclin A2 gene promoter and increases JUNB expression, which in turn binds to the Cyclin A2 gene promoter and promotes its expression, which has been reported in breast and thyroid cancers [130]. The gene discussed is CCNA2; the disease is thyroid gland carcinoma.